Treatment for in-stent restenosis: patient-specific decision rather than universal recommendation

Joo Myung Lee; Jonghanne Park; Tae-Min Rhee; Hyo-Soo Kim

doi:10.21037/jtd.2016.07.57

Letter to the Editor

Treatment for in-stent restenosis: patient-specific decision rather than universal recommendation

Joo Myung Lee, Jonghanne Park, Tae-Min Rhee, Hyo-Soo Kim

Abstract

The development of the drug-eluting stent (DES) created a milestone in the field of percutaneous coronary intervention (PCI) by markedly reducing the rates of in-stent restenosis (ISR) compared to the bare metal stent (BMS).

Letter to the Editor

Treatment for in-stent restenosis: patient-specific decision rather than universal recommendation

Abstract

Article Options

Download Citation

Share